12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Alnylam preclinical data

In a mouse model of beta-thalassemia, ALN-TMP reduced the severity of anemia as demonstrated by an approximate 1 g/dL increase in total hemoglobin...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >